New developments in capmatinib: a list of the latest adverse drug reactions!

Capmatinib is an inhibitor of MET exon 14 skipping mutation in non-small cell lung cancer (NSCLC). Although it has shown significant efficacy in tumor treatment, it is also accompanied by a series of possible adverse reactions. The following is a detailed discussion of the possible adverse effects of capmatinib.

1. Common adverse reactions:

Fatigue: Patients may experience fatigue during treatment with capmatinib. This is a common adverse reaction that may affect the patient's quality of life. When fatigue symptoms are detected, patients should promptly inform their medical team so that appropriate measures can be taken, such as adjusting medication dosage or providing supportive care.

Nausea and Vomiting: Some patients may experience nausea and vomiting while receiving capmatinib. This can have an impact on the patient's diet and fluid intake, so appropriate care and management is required to ensure the patient is able to maintain adequate nutrition and hydration.

Loss of appetite: Some patients may experience a loss of appetite, which may lead to weight loss. The medical team typically monitors patients for changes in weight and intervenes if necessary.

2. Adverse reactions in the digestive system:

Diarrhea: Diarrhea is one of the common adverse reactions in capmatinib treatment. It can be uncomfortable in a patient's life, but appropriate supportive care and fluid management can help relieve this symptom.

Abnormal liver function: Some patients may experience abnormal liver function while receiving capmatinib. This includes conditions such as elevated liver enzyme levels. The medical team will typically monitor a patient's liver function and take appropriate measures, if necessary, to ensure the patient's liver health.

3. Skin and hair reactions:

Skin rash: Skin rash is a common adverse reaction during capmatinib treatment. This may manifest as mild to moderate inflammation of the skin, which may sometimes be accompanied by itching. The medical team can provide appropriate skin care recommendations to alleviate this discomfort.

Hair Pigmentation: Some patients may experience hair pigmentation, which may result in changes in hair color. This is usually a mild adverse reaction, but may have some impact on the patient's appearance.

4. Respiratory system adverse reactions:

Cough: Some patients may experience cough during treatment with capmatinib. This may be due to some effects of the drug on the respiratory system. If the cough persists or worsens, patients should promptly notify the medical team.

5. Adverse reactions of cardiovascular system:

Hypertension: Treatment with capmatinib may cause an increase in blood pressure in some patients. Therefore, during treatment, the medical team will typically monitor the patient's blood pressure regularly and intervene if necessary.

Although capmatinib has shown significant efficacy in the treatment of METExon14skipping mutantNSCLC patients, patients may experience some adverse effects while receiving treatment. Understanding and monitoring these responses is critical to effectively manage patients' treatment and improve quality of life. Patients should always maintain close contact with their medical team and report any discomfort promptly to ensure they receive appropriate support and management. At the same time, medical professionals also need to develop personalized treatment plans based on the patient's condition to minimize the occurrence and impact of adverse reactions.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.